Table 1 Patients’ clinical data
Classification | Number/percentage (n = 66) |
|---|---|
Gender | |
Male | 33 (50%) |
Female | 33 (50%) |
Tumor location | |
Thyroid | 37 (56.1%) |
Pancreas | 14 (21.2%) |
Intestine | 12 (18.2%) |
Lung | 3 (4.5%) |
Metastases | 19 (28.8%) |
Grading classification (WHO 2019) for p-NET, I-NET and lung-NET | |
NET G1 (Ki-67% ≤ 2) | 11 (38%) |
NET G2 (Ki-67% 3–20) | 11 (38%) |
NEC G3 (Ki-67% > 20) | 7 (24%) |
Genetic syndrome | |
Men1 | 1 (2%) |
Men2 | 3 (7%) |
ND | 1 (2%) |
Status | |
Live | 53 (80.3%) |
Dead | 7 (10.6%) |
nd/progression | 6 (9.1%) |